Process Development

This critical phase of drug manufacturing requires that companies take a scientific approach to process design. Our coverage offers insights on how companies can study and understand every aspect of the manufacturing process to optimize their operations. 


Bringing down the barriers to process monitoring in biopharma

How modern process analytical technologies such as Raman spectroscopy can improve quality control
Shutterstock 2219417471

Alleviating bottlenecks in the product life cycle

How the adoption of AI and data-driven techniques can increase efficiencies in pharma manufacturing
Shutterstock 1978782344

Beyond empty and full

The field is in need of more detailed product understanding to increase product safety without sacrificing efficacy

Advancing nanomedicine

Research into nanomaterials has opened the door to new therapeutic strategies

Quantifying technology’s impact on vaccination rates

How reducing technology-addressable vaccine barriers affects coverage rates

Planning your oligonucleotide facility

Two key facility considerations that will impact pharma’s business case

Toward a collaborative pharma ecosystem

A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market

10 tips for improved drug development

Comprehensive strategies to save time and reduce cost in end-to-end clinical development

What’s next in adoptive cell therapy

Overcoming new manufacturing challenges as the cellular immunotherapy landscape expands

The past, present and future of antiviral discovery

New methods and strategies to address the complexities of viral infection offer hope for antiviral drug development

Biopharma 4.0: Industrializing biology

The rapid increase in automated solutions is radically reforming the way scientists discover and develop new therapies

Allogeneic approaches to CAR-T

How off-the-shelf T-cell platforms can make manufacturing CAR-T therapies more feasible and scalable

Minding the gap

As holes in mental health treatment deepen, can pharma fill the voids?

Assessing the nasal drug delivery landscape

New high-throughput screening models provide clinically reproducible and translatable results

The digital twin movement in pharma

How digital-as-twin modeling accelerates process development